Value of radial probe endobronchial ultrasound-guided localization of solitary pulmonary nodules with the combination of ultrathin bronchoscopy and methylene blue prior to video-assisted thoracoscopic surgery.

The aim of this study was to assess the clinical value of radial probe endobronchial ultrasound (RP-EBUS)-guided localization of solitary pulmonary nodules (SPNs) with the combination of ultrathin bronchoscopy and methylene blue prior to video-assisted thoracoscopic surgery (VATS). An ultrathin bronchoscope was used to localize the lesions under RP-EBUS guidance in 48 patients (18 men and 30 women; age range, 41-72 years; mean age, 54 years), who subsequently underwent VATS resection. The lesion size, distance from the parietal pleura, localization time and complications were evaluated. The RP-EBUS-guided localization success rate was 72.9%. The lesion size ± standard deviation was 12.8±4.2 mm and the mean distance from the parietal pleura was 11.2±9.7 mm. The mean localization time was 15.7±8.3 min. The major complication of RP-EBUS-guided localization was asymptomatic hemorrhage in 4 patients (8.3%). The VATS resection success rate was 95.8%. In terms of pathological type, the 48 lesions included atypical adenomatous hyperplasia (n=4), adenocarcinoma in situ (n=5), minimally invasive adenocarcinoma (n=7), adenocarcinoma (n=18), squamous cell carcinoma (n=1), inflammation (n=6), hamartoma (n=4) and tuberculosis (n=3). Therefore, RP-EBUS-guided localization with the combination of an ultrathin bronchoscope and methylene blue prior to VATS resection is a promising technique for SPNs, it plays an important role in the accurate localization of SPNs and it is an effective and safe technique to assist VATS resection of such nodules.

Introduction

The solitary pulmonary nodule (SPN) is defined as an isolated, single lesion of round or oval shape, with a diameter of ≤3 cm, which is located within the lung parenchyma, surrounded entirely by gas-containing lung tissue. Such lesions are not accompanied by lung atelectasis, hilar enlargement or pleural effusion (1,2). With the established role of computed tomography (CT) screening for lung cancer and the wide application of high-resolution CT, SPNs are detected at an increasing rate (3–5). SPN management basically comprises the implementation of immediate surgical treatment (6,7). Over the last decade, video-assisted thoracoscopic surgery (VATS) has become a useful tool in the diagnosis and treatment of SPNs (8,9). However, due to the small size of the nodules, preoperative localization is crucial for the success of VATS.

The preoperative localization methods include microvascular embolisation coils, hookwire insertion and injection of dye (10–15). Each method has its merits and drawbacks. We developed a new technique using a combination of methylene blue and an ultrathin bronchoscope under radial probe endobronchial ultrasound (RP-EBUS) guidance. this technique was applied in 48 patients and achieved effective, safe and convenient SPN localization.

Materials and methods

Patients

Between January, 2013 and September, 2014, RP-EBUS-guided SPN localization with an ultrathin bronchoscope and methylene blue, followed by VATS, was conducted on 48 SPNs from 48 patients who underwent CT examination at the Nanjing Clinical Center of Respiratory Diseases and Imaging (Nanjing, China). The study included 18 men and 30 women, with a mean age of 54 years (range, 41–72 years). Of the 48 patients, 12 had a cancer history. The patient characteristics are summarized in Table I. The study protocol was approved by the Ethics Committee of the Nanjing Chest Hospital and all the patients provided written informed consent.

Table I.

Patient characteristics (n=48).

Characteristics	No. of patients (%)
Age, years
≥60	20 (41.7)
<60	28 (58.3)
Gender
Male	18 (37.5)
Female	30 (62.5)
Cancer history
Yes	12 (25.0)
No	36 (75.0)
Smoking history
Smoker	15 (31.3)
Non-smoker	33 (68.7)

RP-EBUS-guided combination of ultrafine bronchoscopy and methylene blue localization

Each patient had been diagnosed with a pulmonary nodule on a CT scan of the chest, measuring 10 mm (Fig. 1). RP-EBUS scanning was conducted under anesthesia, with percutaneous blood oxygen saturation monitoring and continuous electrocardiography during the examination process. A 2.0-mm, 20-MHz radial mechanical transducer type endobronchial ultrasonic probe (UM-BS20-26R; Olympus, Tokyo, Japan) with a flexible balloon sheath (MAJ-643R; Olympus) was introduced through the 2.8-mm channel of a flexible bronchoscope (XBF-22L; Olympus). The probe was connected to the endobronchial ultrasonography unit (EU-M 20/30; Olympus). The visible bronchial segment was examined until the characteristic ultrasound signal indicating the presence of a solid lesion (Fig. 2). The EBUS probe was removed and 0.3 ml methylene blue was injected at the marked point, according to the angle and depth data.

Figure 1.

Chest CT scan revealing a nodule in the lateral part of the lower lobe of the right lung, measuring 12×10 mm.

Figure 2.

Radial probe endobronchial ultrasound image of a solitary pulmonary nodule with a measured diameter of 12 mm.

VATS

Thoracoscopic segmentectomy was performed under general anesthesia using single-lung ventilation. The technique utilized three incisions. The observation port was ~1 cm in length at the midaxillary line in the 6th or 7th intercostal space. The main operation port was placed in the 3rd or 4th intercostal space at the anterior axillary line. The accessory operation port was usually placed at the posterior axillary line in the 6th intercostal space. Both operation ports were ~2 cm in length.

The methylene blue was visualized during the exploration and the location of the lesion was confirmed (Fig. 3). The initial step was dissection of the hilar lymph nodes to ensure safe sublobar resection. The lymph nodes were sent for frozen section analysis and sublobar resection was abandoned if positive nodes were identified.

Figure 3.

Intraoperative thoracoscopic view of a wedge resection of a pulmonary nodule that was preoperatively marked by methylene blue.

The approach to thoracoscopic segmentectomy begun with ligation of the segmental pulmonary vein and artery using thoracoscopic linear mechanical staplers. The bronchus was further isolated and dissected by stapler. Subsequently, the ipsilateral lung was temporarily reinflated to help identify the segmental fissures. After the fissures were marked with electrocautery and squeezed by long kelly clamps, the segmental plane was finished with an endostapler. In certain cases, we had to convert to a thoracotomy due to problems such as adhesions or failure of localization.

Results

Characteristics of the SPNs

In 35 (72.9%) of the 48 patients, the methylene blue was visualized in or adjacent to the pulmonary nodule as documented following VATS resection (Fig. 4). The maximal diameter of the SPNs, their distance from the pleural surface and their histological diagnosis are summarized in Tables II and III. The diameter of the nodules ± standard deviation (SD) was 12.8±4.2 mm and located at a distance of 11.2±9.7 mm from the pleural surface. A total of 35 nodules were malignant and 13 were benign. A total of 12 lesions were located in the right upper lobe, 10 were in the right lower lobe, 16 in the left upper lobe and 10 in the left lower lobe.

Figure 4.

Lesion raised and resected under video-assisted thoracic surgery.

Table II.

Characteristics of the SPNs (n=48).

Characteristics	Value
Diameter, mm	12.8±4.2
Distance from pleural surface, mm	11.2±9.7
Location, no. (%)
Upper lobe of right lung	12 (25.0)
Lower lobe of right lung	10 (20.8)
Upper lobe of left lung	16 (33.3)
Lower lobe of left lung	10 (20.8)
Density, no. (%)
GGN	18 (37.5)
Solid nodule	30 (62.5)

SPN, solitary pulmonary nodule; GGN, ground-glass nodule.

Table III.

Histological diagnosis of SPNs.

Types	No. of patients (%)
Benign	13 (27.1)
Hamartoma	4 (8.3)
Pulmonary tuberculosis	3 (6.3)
Infammatory pseudotumor	6 (12.5)
Malignant	35 (72.9)
Atypical adenomatous hyperplasia	4 (8.3)
Adenocarcinoma in situ	5 (10.4)
Minimally invasive adenocarcinoma	7 (14.6)
Adenocarcinoma	18 (37.5)
Squamous cell carcinoma	1 (2.1)

SPN, solitary pulmonary nodule.

RP-EBUS-guided SPN localization

The duration of localization, measured from the administration of local anesthesia, ranged between 10 and 28 min (mean, 15 min) and the number of ultrafine bronchoscope insertions or adjustments ranged between 3 and 6 (mean, 3). The only complication of RP-EBUS-guided localization with the combination of an ultrafine bronchoscope and methylene blue was asymptomatic hemorrhage, which was observed in 8.3% of the patients. VATS was performed in all 48 patients; 38 cases underwent wedge resection, including 13 benign and 25 malignant lesions and the remaining 8 patients underwent lobectomy and lymphadenectomy. The mean surgery duration ± SD for wedge resection and lobectomy was 25±8 and 90±30 min, respectively.

In two cases the procedure was converted to thoracotomy: One SPN strongly adhered to the pleural surface and the other was difficult to localize. The characteristics of the RP-EBUS-guided localization with an ultrafine bronchoscope and methylene blue and subsequent VATS are summarized in Table IV.

Table IV.

Characteristics of RP-EBUS-guided SPN localization with a combination of an ultrafine bronchoscope and methylene blue.

Characteristics	Values
Complications, no. (%)
Pneumothorax	0 (0.0)
Hemorrhage	4 (8.3)
Pneumothorax and hemorrhage	0 (0.0)
Duration, min
Range	10–28
Mean	15
Ultrafine bronchoscope insertions, no.
Range	3–6
Mean	3

RP-EBUS, radial probe endobronchial ultrasound; SPN, solitary pulmonary nodule.

Discussion

VATS is a useful minimally invasive procedure for the diagnosis and treatment of peripheral small pulmonary nodules. However, as such lesions may not be visible or palpable during VATS, a conversion from VATS to thoracotomy is occasionally conducted following failure to localize these lesions (16,17). Therefore, it is crucial to accurately localize lesions prior to VATS, particularly in the case of small or faint nodules.

The most common localization method is the CT-guided insertion of a hookwire. However, this technique is associated with the development of pneumothorax and wires may be dislodged with movement (18). The most commonly used dye, methylene blue, may diffuse quickly to the uninvolved pleural surface and make localization difficult (19).

In the present study, 35 lesions were successfully localized. The mean duration of localization ± SD was 15.7±8.3 min and the mean surgery duration for wedge resection and lobectomy was 25±8 and 90±30 min, respectively. All 48 lesions were pathologically examined. Malignant lesions accounted for 72.9% of the cases; this result was similar to previous reports (20–22). We suggest that this may be due to the benign diagnoses of certain patients in this study, who were selected based on imaging results rather than pathological diagnosis.

Although the RP-EBUS-guided method appears to be inferior to the CT-guided hookwire system in terms of successful localization, our technique provides several distinct advantages over other reported techniques, such as introduction of the probe through a natural lumen, absence of pneumothorax, low bleeding rate, no air embolism and no radiation damage.

Our study had several limitations, including the small number of patients and the fact that our localization method was not compared to other methods. Further comparative studies are required to provide a definitive answer on the optimal localization method prior to VATS.

In conclusion, RP-EBUS-guided combination of ultrafine bronchoscopy and methylene blue for the localization of SPNs prior to VATS is an effective, safe and convenient localization method.